Abstract:
PURPOSE: Provided is a process for preparing dry-coated bacteriocin without liquid phase solvent. The prepared dry-coated bacteriocin displays antibacterial activity, has extended storage at normal temperature and is widely used for development of foods and cosmetics containing the bacteriocin as an active ingredient. CONSTITUTION: The process for preparing dry-coated bacteriocin comprises the steps of: mixing bacteriocin and a coating agent in a mixing ratio of 1:1 to 10:1(w/w); inserting the mixture into the hybridization system; and cry-coating the bacteriocin by using the hybridization system.
Abstract:
PURPOSE: A recombinant expression vector for searching a therapeutic agent for treating obesity or diabetes and a searching method using the same are provided to develop the therapeutic agent. CONSTITUTION: A leptin receptor promoter has a base of sequence number 2. The promoter contains a base selected from sequence numbers 3-15. The promoter contains a base of sequence number 9 or 1. A recombinant vector contains the promoter and a reporter gene. The reporter gene is luciferase, HRP(horseraddish peroxidase) or alkaline phosphatase. A cell line transformed with the recombinant vector is ORp-HEK293(KCTC 11920BP). A method for searching a therapeutic agent for treating obesity or diabetes comprises: a step of treating a candidate material for treating obesity or diabetes to a cell line and a step of confirming expression level of the leptin receptor.
Abstract:
PURPOSE: A peptide which suppresses HMG-CoA reductase is provided to competitively suppress the enzyme and to obtain a cholesterol synthesis inhibitor which treats cardiovascular diseases. CONSTITUTION: A peptide contains one or more sequences selected from the group consisting of sequence numbers 1-5. The peptide competitively suppresses HMG-CoA redutase. A cholesterol synthesis inhibitor contains the peptide containing a sequence selected from the group consisting of sequence numbers 1-5. The cholesterol synthesis inhibitor is used for preventing and treating cardiovascular diseases.
Abstract:
PURPOSE: A peptide which suppresses HMG-CoA reductase is provided to suppress cholesterol synthesis and to treat cardiovascular diseases. CONSTITUTION: A peptide which suppresses HMG-CoA reductase contains a sequence selected from sequence numbers 1-5. A cholesterol synthesis inhibitor contains the peptide. The cholesterol synthesis inhibitor is used for treating cardiovascular diseases.
Abstract:
본 발명은 새싹채소 씨앗 불림액에 관한 것으로 보다 상세하게는 새싹채소 씨앗 불림액에 있어서, 천연살균제 또는 천연항균제가 포함되는 새싹채소 씨앗 불림액에 관한 것이다. 본 발명은 미생물적으로 안전한 새싹 채소를 재배하기 위한 씨앗 불림액 제공을 목적으로 한다. 새싹채소, 씨앗, 불림액